Modifying the design of ongoing trials without unblinding

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Methods

Background:

• Group sequential designs offer early stopping for efficacy or futility.
• Conventional designs lack flexibility for unexpected variability.
• Adaptive designs aim to improve trial efficiency and power.

Purpose of the Study:

• To explore enhancing group sequential designs with adaptive sample size adjustments.
• To investigate methods for assessing variability early in a trial.
• To evaluate the impact of adaptive flexibility on trial error rates and power.

Main Methods:

• Examining variability at the first stage before data unblinding.
• Implementing adaptive design changes based on early variability assessment.
• Analyzing the effects on type I error rate and statistical power.

Main Results:

• Adaptive flexibility allows for sample size increases when variability is high.
• Design modifications can include changing the number of stages or interim analysis timing.
• Type I error rate remains largely unaffected by adaptive flexibility.
• Statistical power is influenced by the final total sample size.

Conclusions:

• Adaptive group sequential designs provide enhanced flexibility for clinical trials.
• Early variability assessment enables informed adjustments to trial design.
• These adaptive strategies maintain statistical validity while optimizing resource allocation.